Primary cutaneous CD30+ lymphoproliferative disorder successfully treated by etretinate

Eur J Dermatol. 2012 Sep-Oct;22(5):709-10. doi: 10.1684/ejd.2012.1821.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Combined Modality Therapy
  • Etretinate / therapeutic use*
  • Humans
  • Keratolytic Agents / therapeutic use*
  • Lymphoma, Primary Cutaneous Anaplastic Large Cell / diagnosis
  • Lymphoma, Primary Cutaneous Anaplastic Large Cell / drug therapy*
  • Male
  • Middle Aged
  • PUVA Therapy
  • Skin Neoplasms / diagnosis
  • Skin Neoplasms / drug therapy*

Substances

  • Keratolytic Agents
  • Etretinate